Cargando…

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy

Detalles Bibliográficos
Autores principales:	Bégin, Philippe, Bird, John Andrew, Spergel, Jonathan M., Campbell, Dianne E., Green, Todd D., Bee, Katharine J., Lambert, Romain, Sampson, Hugh A., Fleischer, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545690/ https://www.ncbi.nlm.nih.gov/pubmed/34492123 http://dx.doi.org/10.1111/all.15083

Ejemplares similares

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
por: Remington, Benjamin C., et al.
Publicado: (2021)

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Epicutaneous immunotherapy protects cashew‐sensitized mice from anaphylaxis
por: Pelletier, Benjamin, et al.
Publicado: (2020)

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice
por: Mondoulet, L., et al.
Publicado: (2018)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3(+) Tregs
por: Chen, Xin, et al.
Publicado: (2021)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Efficacy of epicutaneous immunotherapy (EPIT) in a new model of peanut-induced eosinophilic esophagitis (EoE) and allergic enterpathy (AE)
por: Mondulet, Lucie, et al.
Publicado: (2011)

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
por: Dioszeghy, V, et al.
Publicado: (2014)

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut
por: Dioszeghy, Vincent, et al.
Publicado: (2017)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice
por: Dioszeghy, Vincent, et al.
Publicado: (2018)

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense)
por: Mondoulet, Lucie, et al.
Publicado: (2012)

RNA sequencing identifies global transcriptional changes in peripheral CD4(+) cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitis
por: Ruffner, Melanie A, et al.
Publicado: (2021)

Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature
por: Esposito, Susanna, et al.
Publicado: (2018)

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
por: Lins de Holanda Coelho, Gabriel, et al.
Publicado: (2022)

Deep TCR repertoire sequencing reveals relative change in peanut specific clonotype in subjects undergoing rush oral immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2014)

Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes
por: Hervé, Pierre-Louis, et al.
Publicado: (2021)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2018)

Melatonin prevents allergic airway inflammation in epicutaneously sensitized mice
por: Liu, Xudong, et al.
Publicado: (2021)

Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation
por: Inan, Saadet, et al.
Publicado: (2023)

Immunotherapy using algal‐produced Ara h 1 core domain suppresses peanut allergy in mice
por: Gregory, James A., et al.
Publicado: (2016)

Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope‐specific IgE antibody profiling
por: Suprun, Maria, et al.
Publicado: (2022)

Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
por: Uyar, Belkız, et al.
Publicado: (2020)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Activin A Inhibits Antigen-Induced Allergy in Murine Epicutaneous Sensitization
por: Kypriotou, Magdalini, et al.
Publicado: (2013)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy
por: Jagdis, Amanda, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8tg6o1h3pgtjj3ia7u82dcrko1